Abiopharma

🔍 PATTERSON LEONE D (Executive)

Company: Zymeworks Inc. (ZYME)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Acquired 459 shares of Common Stock at $10.55 per share (Direct)
  Date: 2026-01-06 | Code: A | equity_swap_involved: false | shares_owned_after: 459.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Shares of common stock purchased pursuant to the Issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period July 1, 2025 through December 31, 2025. In accordance with the ESPP, the shares of common stock were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025.